Please use this identifier to cite or link to this item:
|Title:||Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria|
Manjunath, Goutham B.
Shome, Bibek R.
|Keywords:||Pharmacology & Pharmacy|
intrinsic antibiotic resistance
|Publisher:||American Chemical Society|
|Citation:||Yarlagadda, V.; Manjunath, G. B.; Sarkar, P.; Akkapeddi, P.; Paramanandham, K.; Shome, B. R.; Ravikumar, R.; Haldar, J., Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria. Acs Infectious Diseases 2016, 2 (2), 132-139 http://dx.doi.org/10.1021/acsinfecdis.5b00114|
ACS Infectious Diseases
|Abstract:||The emergence of drug resistance along with a declining pipeline of clinically useful antibiotics has made it vital to develop more effective antimicrobial therapeutics, particularly against difficult-to-treat Gram-negative pathogens (GNPs). Many antibacterial agents, including glycopeptide antibiotics such as vancomycin, are inherently inactive toward GNPs because of their inability to cross the outer membrane of these pathogens. Here, we demonstrate, for the first time, lipophilic cationic (permanent positive charge) vancomycin analogues were able to permeabilize the outer membrane of GNPs and overcome the inherent resistance of GNPs toward glycopeptides. Unlike vancomycin, these analogues were shown to have a high activity against a variety of multidrug-resistant clinical isolates such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. In the murine model of carbapenem-resistant A. baumannii infection, the optimized compound showed potent activity with no observed toxicity. The notable activity of these compounds is attributed to the incorporation of new membrane disruption mechanisms (cytoplasmic membrane depolarization along with outer and inner (cytoplasmic) membrane permeabilization) into vancomycin. Therefore, our results indicate the potential of the present vancomycin analogues to be used against drug-resistant GNPs, thus strengthening the antibiotic arsenal for combating Gramnegative bacterial infections.|
|Appears in Collections:||Research Papers (Jayanta Haldar)|
Files in This Item:
|1.5 MB||Adobe PDF||View/Open Request a copy|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.